{{Rsnum
|rsid=17606561
|Gene=ELOVL2
|Chromosome=6
|position=10982126
|Orientation=plus
|GMAF=0.185
|Gene_s=ELOVL2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.5 | 43.4 | 53.1
| HCB | 5.1 | 32.8 | 62.0
| JPT | 5.3 | 39.8 | 54.9
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 14.0 | 86.0
| CHB | 5.1 | 32.8 | 62.0
| CHD | 5.5 | 36.7 | 57.8
| GIH | 3.0 | 43.6 | 53.5
| LWK | 0.0 | 4.5 | 95.5
| MEX | 3.4 | 36.2 | 60.3
| MKK | 0.6 | 22.4 | 76.9
| TSI | 2.0 | 45.1 | 52.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22359512
|Trait=None
|Title=Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations.
|RiskAllele=
|Pval=1E-11
|OR=0
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}